Clinical factors associated with outcome in metastatic renal cell carcinoma patients treated with VEGF-targeted therapy

被引：0
|
作者：
Golshayan, A. [1 ]
Choueiri, T. K. [1 ]
Elson, P. [1 ]
Garcia, J. A. [1 ]
Khaswneh, M. [1 ]
Usman, S. [1 ]
Tamaskar, I. [1 ]
Wood, L. [1 ]
Rini, B. I. [1 ]
Bukowski, R. M. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5046
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study
    Harshman, Lauren C.
    Xie, Wanling
    Bjarnason, Georg A.
    Knox, Jennifer J.
    MacKenzie, Mary
    Wood, Lori
    Srinivas, Sandy
    Vaishampayan, Ulka N.
    Tan, Min-Han
    Rha, Sun-Young
    Donskov, Frede
    Agarwal, Neeraj
    Kollmannsberger, Christian
    North, Scott
    Rini, Brian I.
    Heng, Daniel Y. C.
    Choueiri, Toni K.
    LANCET ONCOLOGY, 2012, 13 (09): : 927 - 935
  • [12] Temsirolimus (TEM) in metastatic renal cell carcinoma (mRCC): Safety and efficacy in patients (pts) previously treated with VEGF-targeted therapy
    Wood, L.
    Bukowski, R. M.
    Dreicer, R.
    Elson, P.
    Garcia, J. A.
    Gilligan, T.
    Mekhail, T.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [13] Genetic polymorphisms' influence in outcome of metastatic renal cell cancer patients treated with VEGF-targeted agents.
    Schutz, Fabio Augusto Barros
    Gray, Kathryn P.
    Pomerantz, Mark M.
    Atkins, Michael B.
    Hirsch, Michelle S.
    McDermott, David F.
    Lampron, Megan
    Percy, Andrew
    Lee, Gwo-Shu Mary
    Rosenberg, Jonathan E.
    Signoretti, Sabina
    Kantoff, Philip W.
    Freedman, Matthew
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [14] Gender as a factor associated with poor compliance in the treatment of metastatic renal cell carcinoma with VEGF-targeted therapy in Japanese patients.
    Uemura, Motohide
    Tsujimura, Akira
    Kawashima, Atsunari
    Arai, Yasuyuki
    Tanigawa, Go
    Nin, Mikio
    Yasunaga, Yutaka
    Yoshioka, Toshiaki
    Nomura, Hironori
    Mukai, Masatoshi
    Fukuda, Satoko
    Oka, Daizo
    Nishimura, Kenji
    Yoshida, Takahiro
    Satou, Mototaka
    Hatano, Koji
    Nakai, Yasutomo
    Takayama, Hitoshi
    Nishimura, Kazuo
    Nonomura, Norio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [15] Failure of initial VEGF-targeted therapy in metastatic renal cell carcinoma (mRCC): What next?
    Vickers, M. M.
    Choueiri, T. K.
    Zama, I.
    Cheng, T.
    North, S.
    Knox, J. J.
    Kollmannsberger, C.
    McDermott, D. F.
    Rini, B. I.
    Heng, D. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [16] Predicting outcome to VEGF-targeted therapy in metastatic clear-cell renal cell carcinoma: data from recent studies
    Golshayan, Ali-Reza
    Brick, Ashley J.
    Choueiri, Toni K.
    FUTURE ONCOLOGY, 2008, 4 (01) : 85 - 92
  • [17] The impact of MET expression on patient outcomes with metastatic renal cell carcinoma (mRCC) treated with VEGF-targeted therapy (TT)
    Albiges, Laurence
    De Velasco, Guillermo
    Gray, Kathryn P.
    Carol, Hallie A.
    Caella, Marcella
    Mickey, Suzanne S.
    Fay, Andre P.
    Mcdermott, David F.
    Atkins, Michael B.
    Heng, Daniel Y.
    Signoretti, Sabina
    Choueiri, Toni K.
    BJU INTERNATIONAL, 2015, 116 : 1 - 2
  • [18] Everolimus in patients with metastatic renal cell carcinoma refractory to VEGF-targeted therapy: REACT subgroup analysis of prior therapy.
    Larkin, James M. G.
    Blank, Christian U.
    Bono, Petri
    Gogov, Svetozar
    Panneerselvam, Ashok
    Garay, Carlos A.
    Gruenwald, Viktor
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [19] Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy
    Choueiri, Toni K.
    Garcia, Jorge A.
    Elson, Paul
    Khasawneh, Mohamad
    Usman, Saif
    Golshayan, Ali Reza
    Baz, Rachid C.
    Wood, Laura
    Rini, Brian I.
    Bukowski, Ronald M.
    CANCER, 2007, 110 (03) : 543 - 550
  • [20] VEGF-Targeted Therapy in Metastatic Renal Cell Carcinoma (Retraction of vol 10, pg 191, 2005)
    Rini, Brian
    ONCOLOGIST, 2011, 16 (10): : 1481 - 1481
12345